Nora Apothecary Recalls Lidocaine 2% Injection Due to Sterility Concerns
Nora Apothecary is recalling Lidocaine 2% Injection due to FDA inspection findings regarding quality control and lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable drug, which poses a significant risk of serious injury or infection, meeting the criteria for a Severe rating.
Plain-English summary
Nora Apothecary and Alternative Therapies, Inc. is recalling Lidocaine 2% Injection, 20 ml, with a 30-day expiration date. The recall is being conducted due to FDA inspection findings that raised concerns regarding quality control processes and a lack of assurance of sterility.
The recall includes all products within their expiration date, specifically those dated 90 days prior to April 19, 2013 (January 2013 to April 19, 2013). The products were distributed nationwide.
Consumers and healthcare providers should stop using the recalled products and contact the recalling firm for further instructions or a refund.
The recalled product
- Product
- Lidocaine 2% Inj MDV, 20 ml 30 day expiration,
- Manufacturer
- Nora Apothecary and Alternative Therapies, Inc.
- Category
- Drug — Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 2013 (Jan. 2013 to April 19
- 2013).
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 43 recalled by Nora Apothecary and Alternative Therapies, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 43 products in this recall →Related recalls
Same manufacturer · Nora Apothecary and Alternative Therapies, Inc.
See all →- SevereNora Apothecary Recalls PGE-1 Penile Injections Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
- SevereNora Apothecary Recalls Chlorhexidine Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
- SevereNora Apothecary Recalls Super Trimix Penile Injection Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
- SevereNora Apothecary Recalls Bimix Inj 30:1 Syringes Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
- SevereNora Apothecary Recalls Methylcobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighMartin Avenue Pharmacy Recalls Lidocaine 2% Injectable Due to Sterility Concerns
FDA (Drugs) · 2014-11-05
- SevereRXQ Compounding Recalls Lidocaine HCL 2% Injection Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- SevereLidocaine 1% Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SeverePharmakon Recalls Lidocaine Syringes Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-07-20
- HighLidocaine 2% injectable solution recalled for lack of sterility assurance
FDA (Drugs) · 2022-06-01
- SevereBeacon Hill Medical Pharmacy Recalls B-Complex/Lidocaine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-09-18